Mereo BioPharma Group Plc (MREO)
0.28
+0.04
(+14.47%)
USD |
NASDAQ |
Sep 11, 16:00
0.28
0.00 (0.00%)
After-Hours: 20:00
Mereo BioPharma Group Enterprise Value : 15.61M for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 15.61M |
| September 10, 2026 | 9.955M |
| September 09, 2026 | 9.620M |
| September 08, 2026 | 11.55M |
| September 04, 2026 | 10.82M |
| September 03, 2026 | 14.36M |
| September 02, 2026 | 13.56M |
| September 01, 2026 | 15.08M |
| August 31, 2026 | 13.50M |
| August 28, 2026 | 11.22M |
| August 27, 2026 | 14.33M |
| August 26, 2026 | 15.29M |
| August 25, 2026 | 15.86M |
| August 24, 2026 | 17.12M |
| August 21, 2026 | 17.27M |
| August 20, 2026 | 17.73M |
| August 19, 2026 | 20.63M |
| August 18, 2026 | 20.87M |
| August 17, 2026 | 20.03M |
| August 14, 2026 | 21.81M |
| August 13, 2026 | 20.03M |
| August 12, 2026 | 19.26M |
| August 11, 2026 | 19.68M |
| August 10, 2026 | 14.39M |
| August 07, 2026 | 18.21M |
| Date | Value |
|---|---|
| August 06, 2026 | 19.74M |
| August 05, 2026 | 19.36M |
| August 04, 2026 | 22.33M |
| August 03, 2026 | 21.27M |
| July 31, 2026 | 25.61M |
| July 30, 2026 | 21.19M |
| July 29, 2026 | 19.84M |
| July 28, 2026 | 20.30M |
| July 27, 2026 | 19.13M |
| July 24, 2026 | 16.85M |
| July 23, 2026 | 17.36M |
| July 22, 2026 | 18.41M |
| July 21, 2026 | 19.72M |
| July 20, 2026 | 19.63M |
| July 17, 2026 | 20.41M |
| July 16, 2026 | 22.44M |
| July 15, 2026 | 23.25M |
| July 14, 2026 | 21.03M |
| July 13, 2026 | 22.15M |
| July 10, 2026 | 24.38M |
| July 09, 2026 | 22.66M |
| July 08, 2026 | 21.35M |
| July 07, 2026 | 24.30M |
| July 06, 2026 | 21.45M |
| July 02, 2026 | 24.34M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Biodexa Pharmaceuticals Plc | -- |
| NuCana Plc | -19.30M |
| Silence Therapeutics Plc | 495.01M |
| Autolus Therapeutics Plc | 665.07M |
| BioNTech SE | 7.766B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -7.018M |
| Total Expenses (Quarterly) | 7.018M |
| EPS Diluted (Quarterly) | -0.0437 |
| Earnings Yield | -62.57% |
| Normalized Earnings Yield | -63.39 |